![Laboratory technicians handles capped vials as part of filling and packaging tests for the large-scale production and supply of the University of Oxford’s COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at the Italian biologics’ manufacturing facility of multinational corporation Catalent in Anagni, southeast of Rome, during the COVID-19 infection, caused by the novel coronavirus. Catalent Biologics’ manufacturing facility in Anagni, Italy will serve as the launch facility for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222, providing large-scale vial filling and packaging to British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca. / AFP / Vincenzo PINTO](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/CZR4LEL4MP4YI3VQDXHDZVHUZI.jpg?smart=true&auth=57d259f1c688a8e53e3b2285066505af25537f60c5fb8e155e7e28fc69a2df67&width=400&height=225)
Hostile states are trying to sabotage the UK's vaccine trial. AFP
Hostile states are trying to sabotage the UK's vaccine trial. AFP
UK spy chief Ken McCallum: Hostile states trying to sabotage vaccine trials
Security experts say powerful countries are trying to weaponise the Covid-19 jab